Category Archives: Specialty HUBs

Xspray Pharma Partners with EVERSANA for Launch and Commercialization of Dasynoc (XS004)

Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc

Envision Pharma Group Acquires AI Technology Company OKRA.ai

Envision Pharma Group acquires OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions

Oak Hill Capital Announced the Formation of Petauri Health

Oak Hill Capital partnered with Dan Renick to launch Petauri Health, a purpose-built pharmaceutical commercialization services platform

Trinity Life Sciences Adds Capabilities to Remain in the Forefront of Life Sciences Commercialization

The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults

AscellaHealth Offering Robust Commercialization and Market Access Services

AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey